Rivaroxaban and Multiple allergies - a phase IV clinical study of FDA data

Summary:

Multiple allergies is reported as a side effect among people who take Rivaroxaban (rivaroxaban), especially for people who are male, 60+ old, also take Januvia, and have Asthma.

The phase IV clinical study analyzes which people have Multiple allergies when taking Rivaroxaban. It is created by eHealthMe based on reports of 26,430 people who have side effects when taking Rivaroxaban from the FDA, and is updated regularly.

What is Rivaroxaban?

Rivaroxaban has active ingredients of rivaroxaban. It is often used in blood clots. eHealthMe is studying from 26,543 Rivaroxaban users. Check the latest studies of Rivaroxaban.

What is Multiple allergies?

Multiple allergies (allergy to multiple agents) is found to be associated with 718 drugs and 607 conditions by eHealthMe. Check the latest studies of Multiple allergies.

On Jul, 12, 2026

26,430 people reported to have side effects when taking Rivaroxaban.
Among them, 13 people (0.05%) have Multiple allergies.

Could Rivaroxaban cause Multiple allergies?

Among these 13 people:

What is the gender of people who have Multiple allergies when taking Rivaroxaban? *

female: 23.08 %
male: 76.92 %

What is the age of people who have Multiple allergies when taking Rivaroxaban? *

What are other drugs people take besides Rivaroxaban? *

What are other side effects people have besides Multiple allergies? *

Weight Loss: 10 people, 76.92%
Mycobacterial Infection: 10 people, 76.92%
Bronchiectasis (abnormal widening of the bronchi or their branches, causing a risk of infection): 10 people, 76.92%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 10 people, 76.92%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 10 people, 76.92%
Dyspnea (difficult or laboured breathing): 10 people, 76.92%
Lung Disorder (lung disease): 10 people, 76.92%
Acute Kidney Failure: 10 people, 76.92%
Productive Cough: 10 people, 76.92%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 10 people, 76.92%

What are the existing conditions these people have? *

Asthma: 9 people, 69.23%
Swelling: 2 people, 15.38%
Stroke (sudden death of a portion of the brain cells due to a lack of oxygen): 2 people, 15.38%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 15.38%
Interstitial Lung Disease: 2 people, 15.38%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 15.38%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 15.38%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Rivaroxaban and have Multiple allergies?

- Check whether Multiple allergies is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rivaroxaban:

Rivaroxaban (26,543 reports)

Browse all side effects of Rivaroxaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple allergies:

Multiple allergies (718 drugs)

Browse all the conditions that are associated with Multiple allergies:

Multiple allergies (607 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivaroxaban (the active ingredients of Rivaroxaban) and Rivaroxaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.